Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma

被引:0
|
作者
Tadashi Matsunaga
Fumiaki Sasaki
Mutsuro Ohira
Kohei Hashizume
Akira Hayashi
Yutaka Hayashi
Hideo Mugishima
Naomi Ohnuma
机构
[1] Department of Pediatric Surgery,
[2] Graduate School of Medicine,undefined
[3] Chiba University,undefined
[4] Chiba,undefined
[5] Japan,undefined
[6] ,undefined
[7] Japanese Study Group for Pediatric Liver Tumor (JPLT),undefined
[8] Japan,undefined
[9] Department of Pediatric Surgery,undefined
[10] Graduate School of Medicine,undefined
[11] Chiba University,undefined
[12] 1-8-1 Inohana,undefined
[13] Chuo-ku,undefined
[14] 260-8677,undefined
[15] Chiba,undefined
[16] Japan,undefined
来源
关键词
Hepatoblastoma Lung metastasis Recurrence Stem cell transplantation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:142 / 146
页数:4
相关论文
共 50 条
  • [31] Novel therapeutic approaches in the treatment of children with hepatoblastoma
    Katzenstein, HM
    Rigsby, C
    Shaw, PH
    Mitchell, TL
    Haut, PR
    Kletzel, M
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (09) : 751 - 755
  • [32] Direct results of combined treatment of hepatoblastoma in children
    Hayitov, F. E.
    Mustafaev, T. Q.
    Shukullaev, A. T.
    Iskandarov, K. Z.
    ANNALS OF ONCOLOGY, 2015, 26 : 65 - 65
  • [33] Redefining the role of doxorubicin for the treatment of children with hepatoblastoma
    Malogolowkin, Marcio H.
    Katzenstein, Howard M.
    Krailo, Mark
    Chen, Zhengjia
    Quinn, John J.
    Reynolds, Marleta
    Ortega, Jorge A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) : 2379 - 2383
  • [34] LAPAROSCOPIC LIVER RESECTION FOR TREATMENT OF HEPATOBLASTOMA IN CHILDREN
    Volobuev, Andrew
    Komarov, Igor
    Matinyan, Nune
    Ryabov, Andrew
    Kerimov, Polad
    Rubanskiy, Michael
    Kazantsev, Anatoly
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 715 - 715
  • [35] Outcome of Children with Hepatoblastoma: Analysis of a Single Center Experien in Tunisia About 21Cases
    Chabchoub, I.
    Friou, R.
    Kechiche, N.
    Ammar, N.
    Mosbahi, S.
    Zaghouani, H.
    Nouri, A.
    Zakhama, A.
    Belghith, M.
    Ben Ahmed, S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S271 - S272
  • [36] Docetaxel in the Treatment of Children With Refractory or Relapsed Hepatoblastoma
    George, Sally L.
    Broster, Susan
    Chisholm, Julia C.
    Brock, Penelope
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 (07) : E295 - E297
  • [37] Impact of Radiological Caracteristic of Lung Nodules on Survival in Children with Metastatic Hepatoblastoma
    Neumann, F.
    Pariente, D.
    Brugieres, L.
    Fresneau, B.
    Fabre, M.
    Guettiers, C.
    Branchereau, S.
    Mallon, B.
    Laithierl, V.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S363 - S363
  • [38] Individualized chemotherapy and efficacy analysis of hepatoblastoma in children
    Hu, Huimin
    Zhang, Weiling
    Zhang, Yi
    Gao, Yanan
    Zhi, Tian
    Li, Fan
    Li, Jing
    Gu, Huali
    Liao, Ru
    Wu, Runhui
    Huang, Dongsheng
    PEDIATRIC BLOOD & CANCER, 2024, 71 (01)
  • [39] DELAYED REFERRAL, TREATMENT REFUSAL AND ABANDONMENT, AND OUTCOME FOR HEPATOBLASTOMA IN BANGLADESH
    Yasmin, F.
    Islam, A.
    Chowdhury, Y. J.
    Begum, F.
    Begum, M.
    Nahar, K.
    Karim, M. A.
    Rahman, A. T. M. A.
    Hafiz, G.
    Mollah, L. R.
    Siddique, R.
    Khaleque, A.
    Ara, Z.
    Kibria, C. S. H.
    Ferdouse, Z.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 196 - 196
  • [40] Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma
    Ritz, Annika
    Kolorz, Julian
    Hubertus, Jochen
    Ley-Zaporozhan, Julia
    von Schweinitz, Dietrich
    Koletzko, Sibylle
    Haeberle, Beate
    Schmid, Irene
    Kappler, Roland
    Berger, Michael
    Lurz, Eberhard
    PEDIATRIC BLOOD & CANCER, 2021, 68 (05)